James D. Berry

Affiliations: 
Neurology MGH & Harvard Medical School, Boston, MA, United States 
Google:
"James Berry"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Wills AM, Garry J, Hubbard J, et al. (2019) Nutritional counseling with or without mobile health technology: a randomized open-label standard-of-care-controlled trial in ALS. Bmc Neurology. 19: 104
Berry JD, Paganoni S, Carlson K, et al. (2019) Design and results of a smartphone-based digital phenotyping study to quantify ALS progression. Annals of Clinical and Translational Neurology. 6: 873-881
van den Berg LH, Sorenson E, Gronseth G, et al. (2019) Revised Airlie House consensus guidelines for design and implementation of ALS clinical trials. Neurology
Pattee GL, Plowman EK, Garand KLF, et al. (2019) PROVISIONAL BEST PRACTICES GUIDELINES FOR THE EVALUATION OF BULBAR DYSFUNCTION IN ALS. Muscle & Nerve
Stipancic KL, Yunusova Y, Berry JD, et al. (2018) Minimally Detectable Change and Minimal Clinically Important Difference of a Decline in Sentence Intelligibility and Speaking Rate for Individuals With Amyotrophic Lateral Sclerosis. Journal of Speech, Language, and Hearing Research : Jslhr. 1-15
Green JR, Allison KM, Cordella C, et al. (2018) Additional evidence for a therapeutic effect of dextromethorphan/quinidine on bulbar motor function in persons with ALS: A quantitative speech analysis. British Journal of Clinical Pharmacology
Nicolas A, Kenna KP, Renton AE, et al. (2018) Genome-wide Analyses Identify KIF5A as a Novel ALS Gene. Neuron. 97: 1268-1283.e6
Pattee GL, Plowman EK, Brooks BR, et al. (2017) Best practices protocol for the evaluation of bulbar dysfunction: summary recommendations from the NEALS bulbar subcommittee symposium. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-2
Berry JD, Paganoni S, Atassi N, et al. (2017) Phase IIA Trial of Fingolimod for ALS Demonstrates Acceptable Acute Safety and Tolerability. Muscle & Nerve
Allison KM, Yunusova Y, Campbell TF, et al. (2017) The diagnostic utility of patient-report and speech-language pathologists' ratings for detecting the early onset of bulbar symptoms due to ALS. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-9
See more...